美国大型透析机构自动化腹膜透析处方趋势
该回顾性分析纳入2015至2019年启动自动化腹膜透析并持续至少120天的11659例患者,描述处方随年份、时机及残余肾功能的变化。多数患者接受夜间PD,平均4.9周期、总治疗量9.3L、中位留腹时间7小时;从第1天到第120天处方变化有限,49%患者处方未变。
要点
- 86%患者接受夜间PD,平均4.9周期/天、总治疗量9.3L、中位留腹7小时。
- 第120天较第1天:每交换充盈量平均增100ml,夜间总治疗量平均增0.5L。
- 49%患者第120天处方与初始处方完全相同,处方变异有限。
核心结论
- 在美国迄今最大规模的新发APD处方分析中,多数患者仅接受夜间PD,治疗前4个月内处方变异有限。
研究设计与样本
- 回顾性分析美国一家大型透析机构2015至2019年启动APD且持续PD至少120天的患者数据。
- 队列共11659例,按日历年、PD时机及残余肾功能分类描述处方,并比较第1天与第120天处方变化。
主要发现
- 启动PD时平均年龄从2015年56(15)岁增至2019年58(15)岁,多数其他变量无明确时间趋势。
- 86%患者处方为夜间PD,平均4.9(1.3)周期/天,平均总治疗量9.3(2.5)L,中位每日总留腹时间7(6–9.5)小时。
- 第120天较第1天夜间处方:每日≤3周期和≥6周期患者比例小幅增加,每交换充盈量平均增100ml,夜间总治疗量平均增0.5L。
- 患者层面,49%患者第120天夜间APD处方与初始处方相比无变化。
临床怎么用
- 提示新发APD患者初始处方多固定,需关注个体化调整以匹配透析需求与生活方式。
- 频繁监测和早期个体化处方被视为高质量PD交付的关键前提。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: This is the largest analysis of incident automated peritoneal dialysis (PD) prescriptions conducted in the United States to date. There was limited variability of automated PD prescriptions across the first 4 months of therapy. PD prescriptions tailored to meet the dialysis needs and lifestyle of patients may make PD a more attractive choice and increase longevity on PD. BACKGROUND: Changes in health care policies and recognition of patient benefit have contributed to increases in home-based dialysis, including peritoneal dialysis (PD). Frequent monitoring and early individualization of PD prescriptions are key prerequisites for the delivery of high-quality PD. The present analysis aimed to assess variations in PD prescriptions among incident automated PD (APD) patients who remain on PD for 120+ days. METHODS: This retrospective analysis examined data from patients within a large dialysis organization that initiated PD with APD between 2015 and 2019. PD prescription data were described by calendar year, timing of PD, and residual renal function categories. Changes in prescriptions from PD initiation (day 1) to day 120 were assessed descriptively. RESULTS: The cohort included 11,659 patients. The mean age at PD initiation increased from 2015 (56 [15] years) through 2019 (58 [15] years), whereas most other variables demonstrated no clear temporal change. Most patients (86%) had nighttime PD prescribed, with an average of 4.9 (1.3) cycles per day, a mean total treatment volume of 9.3 (2.5) L, and a median daily total dwell time of 7 (6–9.5) hours. Relative to day 1 nighttime prescriptions, there were (1) small increases in the proportion of patients receiving three or fewer cycles per day and those receiving 6+ cycles per day, (2) a 100 ml mean increase in fill volume per exchange, and (3) a mean 0.5 L increase in total nighttime treatment volume at day 120. When changes in nighttime APD prescriptions were examined at the patient level, 49% of patients had day 120 prescriptions that were unchanged from their initial prescription. CONCLUSIONS: In the largest analysis of incident APD prescriptions conducted in the United States to date, most patients were prescribed nocturnal PD only with limited variability across the first 4 months of therapy.
引用
- Giles HE, Parameswaran V, Lasky R, et al. Trends in Automated Peritoneal Dialysis Prescriptions in a Large Dialysis Organization in the United States. Clin J Am Soc Nephrol. 2024. PMID: 38373051. doi:10.2215/CJN.0000000000000436
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。